Does the angiotensin II receptor antagonist losartan improve cognitive function?

Michele A Tedesco1, Gennaro Ratti, Giovanni Di Salvo

  • 1Department of Cardio-Thoracic and Respiratory Sciences, Second University of Naples, Naples, Italy. Tedesco@napoli.pandora.it

Drugs & Aging
|October 23, 2002
PubMed

Insights

New antihypertensive drugs like angiotensin II receptor antagonists may improve cognitive function in hypertensive patients. This benefit extends beyond blood pressure reduction, suggesting broader impacts on brain health and quality of life.

Area of Science:

  • Pharmacology
  • Neurology
  • Cardiology

Background:

  • Chronic hypertension is linked to cerebrovascular and cardiovascular diseases.
  • Hypertension is associated with reduced cognitive function, particularly in untreated patients.
  • Newer antihypertensive agents may offer additional patient benefits beyond blood pressure control.

Purpose of the Study:

  • To investigate the cognitive effects of angiotensin II receptor antagonists in hypertensive patients.
  • To explore potential mechanisms beyond blood pressure reduction for cognitive improvements.

Main Methods:

  • An initial clinical trial was conducted.
  • The study involved patients with hypertension, including elderly individuals.
  • The effects of the angiotensin II receptor antagonist losartan were assessed.

Main Results:

  • Losartan demonstrated an improvement in cognitive function in hypertensive patients.
  • Cognitive benefits were observed even in elderly participants.
  • The observed cognitive improvements were not solely attributable to blood pressure reduction.

Conclusions:

  • Angiotensin II receptor antagonists may positively impact cognitive function in hypertensive individuals.
  • The renin-angiotensin system's biological actions likely play a role in these cognitive effects.
  • Improving cognitive function in hypertension offers potential economic and quality-of-life benefits, especially for the aging population.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...